Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Novel Influenza A (H1N1)”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Post-approval studies (Phase 4)Study completedNCT00935194
What this trial is testing

Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study

Who this might be right for
Influenza
Capital Medical University 102
Not applicableStudy completedNCT01024673
What this trial is testing

Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)

Who this might be right for
Influenza
University of Pittsburgh 38
Large-scale testing (Phase 3)Study completedNCT01032408
What this trial is testing

Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection

Who this might be right for
H1N1 Influenza VirusHuman Immunodeficiency Virus Type 1 (HIV-1) Infection
Chiltern Pesquisa Clinica Ltda 154
Not applicableStudy completedNCT05797103
What this trial is testing

The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus

Who this might be right for
Bacterial GrowthNovel Influenza A (H1N1)
Dove Medical Press Ltd 20
Post-approval studies (Phase 4)Study completedNCT00956111
What this trial is testing

A Clinical Trial With Influenza A/H1N1 Vaccines

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 1,614
Not applicableStudy completedNCT01289418
What this trial is testing

Surveillance for Adverse Events Following Pandemic H1N1 Immunization

Who this might be right for
Novel Influenza A/H1N1
PHAC/CIHR Influenza Research Network 6,525
Not applicableStudy completedNCT05572450
What this trial is testing

Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain

Who this might be right for
Influenza A H1N1
Hvivo 70
Not applicableStudy completedNCT01617317
What this trial is testing

H-IVIG Treatment for Severe H1N1 2009

Who this might be right for
Novel 2009 Influenza A (H1N1) Infection
The University of Hong Kong 34
Large-scale testing (Phase 3)Study completedNCT01031719
What this trial is testing

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors

Who this might be right for
H1N1 Influenza VirusInvasive Solid Tumors
Chiltern Pesquisa Clinica Ltda 59
Post-approval studies (Phase 4)Study completedNCT01079273
What this trial is testing

Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects

Who this might be right for
Influenza
Opera CRO, a TIGERMED Group Company 7
Not applicableStudy completedNCT01046331
What this trial is testing

Novel Influenza A (H1N1) Surveillance Registry

Who this might be right for
Novel Influenza AH1N1Influenza
National Heart, Lung, and Blood Institute (NHLBI) 894
Not applicableStudy completedNCT01037855
What this trial is testing

Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine

Who this might be right for
Novel Influenza A (H1N1)A New Flu Virus of Swine Origin
Novartis Vaccines 4,028
Large-scale testing (Phase 3)Study completedNCT01032395
What this trial is testing

Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus

Who this might be right for
H1N1 Influenza VirusChronic Pulmonary DiseaseChronic Heart Disease+1 more
Chiltern Pesquisa Clinica Ltda 342
Large-scale testing (Phase 3)Study completedNCT00971100
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 752
Large-scale testing (Phase 3)Study completedNCT00973349
What this trial is testing

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults

Who this might be right for
Influenza
Novartis 2,719
Not applicableStudy completedNCT01192958
What this trial is testing

Validate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v Influenza

Who this might be right for
H1N1 Virus
Public Health England
Testing effectiveness (Phase 2)Study completedNCT00992212
What this trial is testing

Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10

Who this might be right for
Pandemic Influenza Disease
Novartis Vaccines 418
Not applicableStudy completedNCT01022931
What this trial is testing

Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva

Who this might be right for
HealthyImmunosuppressedAsthmatic+1 more
University Hospital, Geneva 200
Testing effectiveness (Phase 2)Study completedNCT00975572
What this trial is testing

Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older

Who this might be right for
Virus DiseasesRespiratory Tract DiseasesRespiratory Tract Infections+2 more
Jiangsu Province Centers for Disease Control and Prevention 2,200
Large-scale testing (Phase 3)Study completedNCT00970177
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 812
Next Page